← Back to Search

Virus Therapy

TTAC-0001 for Glioblastoma

Phase 2
Waitlist Available
Research Sponsored by PharmAbcine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up until time of progressive disease or 1 year
Awards & highlights

Study Summary

This study is evaluating whether a drug may help treat recurrent glioblastoma.

Eligible Conditions
  • Glioblastoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~until time of progressive disease or 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and until time of progressive disease or 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Secondary outcome measures
Disease control rate
Objective response rate
Overall survival
+3 more
Other outcome measures
Change in concentration of serum angiogenic factor or receptor
Magnetic Resonance Imaging
Immunogenicity
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: TTAC-0001Experimental Treatment1 Intervention
TTAC-0001 with dose assigned to each dose group will be administered
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Olinvacimab
Not yet FDA approved

Find a Location

Who is running the clinical trial?

PharmAbcineLead Sponsor
7 Previous Clinical Trials
191 Total Patients Enrolled
2 Trials studying Glioblastoma
21 Patients Enrolled for Glioblastoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
2019. "TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03856099.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top